BP000165-C071: Recombinant Human Interleukin-1 family member 5 (IL1F5) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000165-CYT-009: Recombinant Human Interleukin-1 family member 5 (IL1F5) Protein
Source: E. coli-derived.
As measured by its binding ability in a functional ELISA, immobilized IL1F5 at 1 ?/ml (100 ul/well) can bind rHuIL-1 Rrp2/Fc Chimera with a linear range of 0.15-5 ug/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000165-CYT-154: Recombinant Mouse Interleukin-1 family member 5 (IL1F5) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. Measured by its ability to inhibit IL-36a, IL-36b or IL-36g induced IL-6 secretion by NIH-3T3 mouse embryonic fibroblast cells. The ED50 for this effect is typically 0.8-4 ug/ml (corresponding to a specific activity of 250-125 units/mg) in the presence of 15 ug/ml of recombinant mouse IL-36b.
Purity: > 95.0% by SDS-PAGE.BP002452-CYT-160: Recombinant Human Interleukin-36 Gamma (IL36G) Protein
Source: E. coli-derived.
Measured by its binding ability in a functional ELISA to bind recombinant human IL-1 Rrp2 Fc Chimera.
Purity: > 95.0% as determined by RP-HPLC and SDS-PAGE.BP002452-CYT-161: Recombinant Human Interleukin-36 Gamma (152 a.a) (IL36G) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. The ED50 as measured by its ability to induce IL-8 secretion in human preadipocytes is less than 15 ng/ml, corresponding to a Specific Activity of 67,000 IU/mg.
Purity: > 95.0% as determined by SDS-PAGE.